Previous Close | 5.00 |
Open | 5.05 |
Bid | 3.85 x 1200 |
Ask | 5.05 x 2000 |
Day's Range | 4.92 - 5.05 |
52 Week Range | 3.25 - 6.05 |
Volume | 51,509 |
Avg. Volume | 107,463 |
Market Cap | 90.524M |
Beta | 2.53 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.61 |
Earnings Date | Feb 6, 2018 - Feb 12, 2018 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 8.00 |
Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that it has dosed the first patient in the Company’s Phase 1/2 clinical trial evaluating the safety and efficacy of an investigational AAV-based gene therapy for the treatment of X-linked retinitis pigmentosa (XLRP). The multicenter study will assess AGTC’s novel recombinant AAV vector expressing a human RPGR gene (the rAAV2tYF-GRK1-RPGR) in patients with XLRP. The patient is being followed by Dr. David Birch of Retina Foundation of the Southwest and the surgery was performed by Dr. Andreas Lauer of Oregon Health & Science University.
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 10, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 14, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
Stock Monitor: Applied Genetic Technologies Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 12, 2018 / Active-Investors.com has just released a free research report on Catalyst Biosciences, ...
Q2 2018 Applied Genetic Technologies Corp Earnings Call
The Alachua, Florida-based company said it had a loss of 29 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 09, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
NEW YORK, NY / ACCESSWIRE / February 9, 2018 / Applied Genetic Technologies Corp. (NASDAQ: AGTC ) will be discussing their earnings results in their Q2 Earnings Call to be held on February 9, 2018 at 8:00 ...
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 01, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Applied Genetic Technologies Corp. Here are 5 ETFs with the largest exposure to AGTC-US. Comparing the performance and risk of Applied Genetic Technologies Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis Applied Genetic Technologies Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Applied Genetic Technologies Corp. – bluebird bio, Inc., Organovo Holdings, Inc., Eiger BioPharmaceuticals, Inc., Apollo Endosurgery, Inc. and Dicerna Pharmaceuticals, Inc. (BLUE-US, ONVO-US, EIGR-US, APEN-US and DRNA-US) ... Read more (Read more...)
Q1 2018 Applied Genetic Technologies Corp Earnings Call
Applied Genetic Technologies Corporation (NASDAQ:AGTC) is trading with a trailing P/E of 153.2x, which is higher than the industry average of 26.9x. While AGTC might seem like a stock toRead More...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Applied Genetic Technologies Corp. Here are 5 ETFs with the largest exposure to AGTC-US. Comparing the performance and risk of Applied Genetic Technologies Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
LONDON, UK / ACCESSWIRE / October 2, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Applied Genetic Technologies Corp. (NASDAQ: AGTC ) ("Applied Genetic"), which ...
Research Desk Line-up: Applied Genetic Technologies Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 25, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Aviragen Therapeutics, ...